Sandostatin Related Clinical Trials
A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study. [Completed]
Pegvisomant And Sandostatin LAR Combination Study [Completed]
Ultrasound Guided Sandostatin LAR Injection in Acromegaly [Recruiting]
Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers [Recruiting]
Preoperative Octreotide Treatment of Acromegaly [Active, not recruiting]
Effects of Sandostatin LAR� in Acromegaly [Recruiting]
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours [Recruiting]
Sandostatine® LP and Hyperinsulinism [Recruiting]
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea [Completed]
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed [Completed]
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma [Active, not recruiting]
Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea [Recruiting]
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel [Recruiting]
Effects of Intraarterial Octreotide on Pancreatic Texture [Recruiting]
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients [Active, not recruiting]
Everolimus and LongActing Octreotide Trial in Polycystic Livers [Recruiting]
Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg, Imported And Distributed By The Laboratory Chemical Pharmaceutical Bergamo Ltda., Compared To Product Sandostatin LAR ® (Octreotide Acetate LAR) 30 MG Manufactured By Novartis Biosciences S / A. [Not yet recruiting]
Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers [Recruiting]
Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas [Recruiting]
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas [Recruiting]
Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD) [Not yet recruiting]
Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome [Recruiting]
Treatment of Acromegaly With a Somatostatin Analog Before Pituitary Surgery for Acromegaly: Comparison With Neurosurgery Alone [Recruiting]
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache [Recruiting]
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly [Completed]
Sandostatin for Patients With Androgen Independent Prostate Cancer [Recruiting]
Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding [Recruiting]
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly [Recruiting]
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer [Active, not recruiting]
Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome [Recruiting]
Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease [Recruiting]
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer [Active, not recruiting]
Acute Application of Pegvisomant and Octreotide in Acromegaly [Completed]
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly [Completed]
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction [Completed]
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly [Completed]
Prediction of Tumor Shrinkage in Acromegaly [Completed]
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly [Completed]
Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients [Completed]
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma [Completed]
Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome [Terminated]
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) [Recruiting]
Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas [Completed]
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly [Recruiting]
Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients [Completed]
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly [Recruiting]
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor [Recruiting]
Octreotide in Treating Patients With Cancer-Related Malignant Ascites [Recruiting]
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer [Active, not recruiting]
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis [Active, not recruiting]
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly [Recruiting]
Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut [Active, not recruiting]
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer [Completed]
Evaluation of the Efficacy of Long-Acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma [Completed]
A Study of Octreotide Depot Vs Saline Control in Pediatric Hypothalamic Obesity Patients [Completed]
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis [Completed]
Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity [Completed]
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Active, not recruiting]
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors [Withdrawn]
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients [Completed]
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer [Active, not recruiting]
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis [Completed]
Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-naïve Patients With Acromegaly [Completed]
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma [Recruiting]
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. [Active, not recruiting]
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma [Recruiting]
Extension Study of the Long-Term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-Proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy [Completed]
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea [Completed]
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]
Extension Study of Long-Term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-Proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy [Completed]
Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma [No longer recruiting]
A Study of IMC-A12 in Islet Cell Cancer [Recruiting]
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [Completed]
Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide [Recruiting]
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR [No longer recruiting]
Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure [Not yet recruiting]
Octreotide Efficacy and Safety in First-Line Acromegalic Patients [Suspended]
Octreotide in Severe Polycystic Liver Disease [Recruiting]
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma [Active, not recruiting]
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy [Completed]
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy [Completed]
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction [Completed]
Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors [Recruiting]
IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC [Recruiting]
Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors [Not yet recruiting]
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors [Recruiting]
Treatment of Orthostatic Intolerance [Recruiting]
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer [Recruiting]
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low- or Intermediate-Grade Neuroendocrine Cancer [Recruiting]
Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers [Recruiting]
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors [Recruiting]
Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients [Recruiting]
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide [Recruiting]
Preoperative Octreotide Treatment of Patients With Acromegaly [No longer recruiting]
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours [Recruiting]
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma [Completed]
A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide [Completed]
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia [Completed]
Treatment of Orthostatic Hypotension in Autonomic Failure [Recruiting]
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors [No longer recruiting]
Alternatives to Large Volume Paracentesis Study [Recruiting]
|
